Close Menu

NEW YORK (GenomeWeb) – Genomic services provider Macrogen said on Tuesday that it has signed a one-year agreement to be the exclusive buyer of Exosome Plus' Exo2D exosome isolation kits.

The South Korean companies have also signed a memorandum of understanding to collaborate on the development of exosome-based biomedical products including diagnostics and therapeutics.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
24
Sponsored by
SCHOTT MINIFAB

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.